Quizartinib for induction, consolidation and maintenance treatment of newly diagnosed FLT3-ITD-positive acute myeloid leukaemia

Supporting evidence

• Evaluation report

• Committee papers (PDF 10.43 MB)

  Published:

  23 October 2024